Qiriat-Arbaa, Israel

Serguei Finogueev


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Qiriat Arabaa, IL (2006)
  • Qiriat Arbaa, IL (2006 - 2009)

Company Filing History:


Years Active: 2006-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Serguei Finogueev

Introduction

Serguei Finogueev is a notable inventor based in Qiriat-Arbaa, Israel. He has made significant contributions to the field of pharmaceuticals, particularly through his work with Teva Pharmaceutical Industries Limited. With a total of three patents to his name, Finogueev has demonstrated a commitment to advancing medical science.

Latest Patents

Among his latest patents is a novel crystal form of pioglitazone hydrochloride. This invention includes a method for producing this new crystal form, as well as a method for creating a known crystal form of pioglitazone hydrochloride. His work in this area showcases his innovative approach to pharmaceutical development.

Career Highlights

Finogueev's career at Teva Pharmaceutical Industries Limited has been marked by his dedication to research and development. His expertise in creating new pharmaceutical formulations has positioned him as a valuable asset to the company. His contributions have not only advanced the company's portfolio but have also had a positive impact on patient care.

Collaborations

Throughout his career, Serguei Finogueev has collaborated with esteemed colleagues such as Jean Hildesheim and Shlomit Wizel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Serguei Finogueev's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving healthcare through scientific advancement. His contributions will continue to influence the field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…